tiprankstipranks
Trending News
More News >
Link-Asia International Medtech Group Ltd. (HK:1143)
:1143
Hong Kong Market

Link-Asia International Medtech Group Ltd. (1143) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Link-Asia International Medtech Group Ltd. has a market cap or net worth of HK$82.99M. The enterprise value is HK$108.48M.
Market CapHK$82.99M
Enterprise ValueHK$108.48M

Share Statistics

Link-Asia International Medtech Group Ltd. has 224,289,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,289,180
Owned by Insiders
Owned by Institutions

Financial Efficiency

Link-Asia International Medtech Group Ltd.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 1.52%.
Return on Equity (ROE)0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)1.52%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee574.03K
Profits Per Employee9.62K
Employee Count835
Asset Turnover0.54
Inventory Turnover7.90

Valuation Ratios

The current PE Ratio of Link-Asia International Medtech Group Ltd. is 8.39. Link-Asia International Medtech Group Ltd.’s PEG ratio is 0.03.
PE Ratio8.39
PS Ratio0.00
PB Ratio0.17
Price to Fair Value0.13
Price to FCF0.60
Price to Operating Cash Flow0.55
PEG Ratio0.03

Income Statement

In the last 12 months, Link-Asia International Medtech Group Ltd. had revenue of 479.32M and earned 8.04M in profits. Earnings per share was 0.04.
Revenue479.32M
Gross Profit123.60M
Operating Income15.18M
Pretax Income10.36M
Net Income8.04M
EBITDA4.78M
Earnings Per Share (EPS)0.04

Cash Flow

In the last 12 months, operating cash flow was -10.11M and capital expenditures -697.00K, giving a free cash flow of -10.80M billion.
Operating Cash Flow-10.11M
Free Cash Flow-10.80M
Free Cash Flow per Share-0.05

Dividends & Yields

Link-Asia International Medtech Group Ltd. pays an annual dividend of HK$0.273, resulting in a dividend yield of ―
Dividend Per ShareHK$0.273
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.57
52-Week Price Change-83.91%
50-Day Moving Average0.30
200-Day Moving Average0.70
Relative Strength Index (RSI)68.06
Average Volume (3m)918.53K

Important Dates

Link-Asia International Medtech Group Ltd. upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 31, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend DateJun 04, 2015

Financial Position

Link-Asia International Medtech Group Ltd. as a current ratio of 2.66, with Debt / Equity ratio of 14.19%
Current Ratio2.66
Quick Ratio2.51
Debt to Market Cap0.58
Net Debt to EBITDA-47.21
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Link-Asia International Medtech Group Ltd. has paid 3.90M in taxes.
Income Tax3.90M
Effective Tax Rate0.38

Enterprise Valuation

Link-Asia International Medtech Group Ltd. EV to EBITDA ratio is -33.09, with an EV/FCF ratio of 0.00.
EV to Sales-0.33
EV to EBITDA-33.09
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Link-Asia International Medtech Group Ltd. has HK$312.05M in cash and marketable securities with HK$86.60M in debt, giving a net cash position of -HK$225.45M billion.
Cash & Marketable SecuritiesHK$312.05M
Total DebtHK$86.60M
Net Cash-HK$225.45M
Net Cash Per Share-HK$1.01
Tangible Book Value Per ShareHK$2.48

Margins

Gross margin is 19.16%, with operating margin of 3.17%, and net profit margin of 1.68%.
Gross Margin19.16%
Operating Margin3.17%
Pretax Margin2.16%
Net Profit Margin1.68%
EBITDA Margin1.00%
EBIT Margin-1.70%

Analyst Forecast

The average price target for Link-Asia International Medtech Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-4.52%
EPS Growth Forecast55.30%

Scores

Smart Score1
AI Score47
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis